Mereo BioPharma Group (STU:MAH0) Accumulated Depreciation : €-0.94 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Mereo BioPharma Group Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Mereo BioPharma Group's quarterly accumulated depreciation increased from Sep. 2024 (€-0.87 Mil) to Dec. 2024 (€-0.91 Mil) and increased from Dec. 2024 (€-0.91 Mil) to Mar. 2025 (€-0.94 Mil).

Mereo BioPharma Group's annual accumulated depreciation increased from Dec. 2022 (€-0.70 Mil) to Dec. 2023 (€-0.73 Mil) and increased from Dec. 2023 (€-0.73 Mil) to Dec. 2024 (€-0.91 Mil).

Mereo BioPharma Group Accumulated Depreciation Historical Data

The historical data trend for Mereo BioPharma Group's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Accumulated Depreciation Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-2.03

-1.89

-0.70

-0.73

-0.91

Mereo BioPharma Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-0.77	-0.82	-0.87	-0.91	-0.94

Mereo BioPharma Group Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Mereo BioPharma Group Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (STU:MAH0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

MREO:USA 0A9G:UK

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines